SCHEMBL29414902

SCHEMBL29414902

Cc1cc([N+](=O)[O-])ccc1Oc1ccnc(NN)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.42
TDP1 Q9NUW8 3/20 0.42
CYP3A4 P08684 2/20 0.42
TSHR P16473 2/20 0.41
MEN1 O00255 6/20 0.40
KMT2A Q03164 6/20 0.40
MAPT P10636 5/20 0.40
TGFBR1 P36897 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
PDE7A Q13946 1/20 0.40
HTT P42858 3/20 0.39
GAA P10253 3/20 0.39
KDM4E B2RXH2 1/20 0.39
LMNA P02545 1/20 0.39
GLA P06280 1/20 0.39
THRB P10828 1/20 0.39
MAPK1 P28482 1/20 0.38
HSPB1 P04792 1/20 0.38
PKM P14618 1/20 0.37
S1PR4 O95977 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15015164 1.00 ALDH1A1 (0.42) ALDH1A1TDP1CYP3A4TSHRMEN1
SCHEMBL28054973 0.86 POLB (0.46) ALDH1A1MEN1KMT2AMAPTGAA
SCHEMBL27727905 0.85 TBXA2R (0.41) ALDH1A1TDP1TSHRMEN1KMT2A
SCHEMBL29414896 0.84 ALDH1A1 (0.49) ALDH1A1TDP1CYP3A4TSHRMEN1
SCHEMBL1192691 0.84 ALDH1A1 (0.49) ALDH1A1TDP1CYP3A4TSHRMEN1
SCHEMBL29083270 0.81 KDR (0.57)
SCHEMBL24168282 0.81 PDE7A (0.45) ALDH1A1TDP1CYP3A4TSHRMEN1
SCHEMBL29414899 0.81 PDE7A (0.45) ALDH1A1TDP1CYP3A4TSHRMEN1
SCHEMBL30127582 0.81 ALDH1A1 (0.42) ALDH1A1TDP1CYP3A4TSHRMEN1
SCHEMBL1193072 0.80 KDR (0.42) MEN1KMT2AMAPTGAAPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114031619-A Preparation method of intermediate of Tecatinib 山东汇海医药化工有限公司 2022-02-11 CN claimed
CN-114031619-A Preparation method of intermediate of Tecatinib 山东汇海医药化工有限公司 2022-02-11 CN disclosed